Bromelain with peroxidase from pineapple are more potent to target leukemia growth inhibition - A comparison with only bromelain.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 20 06 2018
revised: 29 10 2018
accepted: 11 11 2018
pubmed: 20 11 2018
medline: 15 1 2019
entrez: 20 11 2018
Statut: ppublish

Résumé

The natural anti-cancer agent bromelain is found to be beneficial for either single or multi-targeted therapy in gastric and skin carcinoma, by inhibiting cancer cell growth. Importantly, the presence of peroxidase enhances its biological efficiency. We have now evaluated a panel of cancer cell lines with bromelain in presence or absence of peroxidase to identify that the combination has higher apoptosis inducing potential in all those cell lines. Bromelain plus peroxidase (BM-PR) inhibited acute myeloid (K562) cell proliferation and altered the morphological features. Incidence of apoptosis was established by using annexin V exposure and this was confirmed that the cell cycle was arrested at G0/G1 phase in a concentration-dependent manner. BM-PR increased the intracellular ROS level and altered the mitochondrial membrane potential, as detected using dichlorofluores cin diacetate (DCFDA). It also regulated the expression of apoptosis-related proteins like Bax, Bcl2, caspase-3 and cytochrome besides causing up-regulation of p53 as determined by western blot analysis. These results suggest that BM-PR from pineapple induces apoptosis better than only bromelain in acute myeloid leukemia cells possibly via mitochondria dependent pathway.

Identifiants

pubmed: 30453006
pii: S0887-2333(18)30293-5
doi: 10.1016/j.tiv.2018.11.004
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Reactive Oxygen Species 0
Bromelains 9001-00-7
Peroxidase EC 1.11.1.7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

24-32

Informations de copyright

Copyright © 2018. Published by Elsevier Ltd.

Auteurs

Rahul Debnath (R)

Immunology Microbiology Lab, Department of Human Physiology, Tripura University, Suryamaninagar, 799102 Agartala, Tripura, India.

Nabanita Chatterjee (N)

Research Institute in Oncology & Hematology, Cancer Care Manitoba, Winnipeg, MB R3E OV9, Canada.

Subhadip Das (S)

Department of Pathology, Wexner Medical Center,The Ohio State University, Columbus, OH, USA.

Snehasis Mishra (S)

Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, India.

Dipayan Bose (D)

Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, India.

Somenath Banerjee (S)

Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, India.

Sujata Das (S)

Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, India.

Krishna Das Saha (KD)

Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, India. Electronic address: Krishna@iicb.res.in.

Durgadas Ghosh (D)

Department of Zoology, Tripura University, Suryamaninagar, 799102 Agartala, Tripura, India.

Debasish Maiti (D)

Immunology Microbiology Lab, Department of Human Physiology, Tripura University, Suryamaninagar, 799102 Agartala, Tripura, India. Electronic address: debasish.maiti@tripurauniv.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH